Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 124Lymphoma 71Lymphoma, Non-Hodgkin 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 52Myelodysplastic Syndromes 50Neoplasms, Plasma Cell 48Hodgkin Disease 48Leukemia 42Leukemia, Lymphocytic, Chronic, B-Cell 40Lymphoma, Mantle-Cell 35Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 33Burkitt Lymphoma 24Lymphoma, B-Cell, Marginal Zone 22Lymphoma, Large-Cell, Immunoblastic 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Myeloproliferative Disorders 20Recurrence 19Hematologic Neoplasms 19Immunoglobulin Light-chain Amyloidosis 18Leukemia, Myelomonocytic, Chronic 16Neuroblastoma 15Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 12Primary Myelofibrosis 12

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Sugars 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuromyelitis Optica × Melphalan × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡